Sleep Diseases News Monitoring

Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea

The Food and Drug Administration on Friday approved the use of Eli Lilly medicine Zepbound, already prescribed for weight loss, as a treatment for sleep apnea in obese patients. The active chemical in Zepbound, tirzepatide, is also prescribed for treating …

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

The Food and Drug Administration has authorized the use of Zepbound for adults with obesity and moderate to severe obstructive sleep apnea. Getty Images/iStockphoto hide caption toggle caption Getty Images/iStockphoto The weight loss drug Zepbound …

FDA Approves First Prescription Drug for Obstructive Sleep Apnea

Sat 21 Dec 2024 | 05:58 PM The US Food and Drug Administration (FDA) has approved Zepbound, the first prescription medication for treating obstructive sleep apnea (OSA), marking a major breakthrough in addressing this widespread sleep disorder. Zepbound, …

FDA approves weight-loss drug Zepbound to treat sleep apnea

FDA approves first-ever medication for obstructive sleep apnea

The Food and Drug Administration announced late Friday that it has approved Zepbound to treat obstructive sleep apnea for those who are moderately or severely obese. The drug is to be used in conjunction with a reduced-calorie diet and physical activity, …

USFDA approves Eli Lilly weight loss treatment Zepbound for obstructive sleep apnea

Indianapolis: Eli Lilly and Company has announced the U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide) as a prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Zepbound may help …

Regulators approve first drug treatment for obstructive sleep apnea

U.S regulators have approved the first drug treatment for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The U.S Food and Drug Administration (FDA) on Friday, December 19 said that Zepbound (tirzepatide) will be used in …

First Treatment Drug Introduced for Sleep Apnea

U.S. regulators have approved the first drug treatment for sleep apnea, allowing the use of a weight-loss medication to address the condition, which affects millions of Americans. “This is a significant breakthrough for patients with obstructive sleep …

Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity

Tirzepatide (Zepbound) has gained another approval, now as the first and only prescription drug for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. The drug is recommended to be used alongside a reduced-calorie diet and increased …

FDA expands weight loss drug Zepbound approval to treat sleep apnea

The FDA has approved Eli Lilly’s obesity treatment, Zepbound, for the management of moderate to severe obstructive sleep apnea in people with obesity. This marks the first time a medication has been approved to treat this condition. The link between …

Zepbound Approved For Sleep Apnea

Topline The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound approved as a weight-loss drug last year. A sign for …

Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to treat patients with obstructive sleep apnea, said …

FDA approves weight loss drug Zepbound for sleep apnea

The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday. The decision makes it the first drug treatment for the disorder, which affects …

THIS weight-loss drug becomes first to gain approval for treating sleep apnea; details here

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder, as reported by …

STAT+: Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.

The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S. Zepbound, whose scientific name is tirzepatide, has now been specifically approved for patients with both …

FDA approves Zepbound as first ever prescription drug to treat sleep apnea with obesity

The U.S. Food and Drug Administration (FDA) approved tirzepatide (Zepbound) on Dec. 20, making it the first and only prescription medication indicated for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity, according to an …

US approves first drug treatment for sleep apnea

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans. "This is a major step forward for patients with obstructive sleep apnea,…

FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

The US FDA approved tirzepatide (Zepbound; Eli Lilly and Company) on December 20, 2024, as the first and only prescription medication indicated for adults with moderate-to-severe obstructive sleep apnea (OSA) who also have obesity, according to a company …

Lilly's Zepbound scores 2nd approval with landmark FDA nod in obstructive sleep apnea

Christmas has come early for Eli Lilly this year, courtesy of a fresh FDA approval for the Indianapolis drugmaker’s obesity star Zepbound. With the FDA’s green light on Friday, Lilly’s dual GIP/GLP-1 blockbuster Zepbound has become the first …

HomeCareList.org Launches to Revolutionize Access to Home Care Services

Revolutionary online platform simplifies the search for quality home care, connecting families with trusted agencies while helping providers grow their business PHOENIX, AZ, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- HomeCareList.org …

Combination of Addiction and Mental Health Treatment Improving Recovery Results

Integrated treatment programs combining addiction and mental health care deliver superior outcomes, reducing relapse rates and transforming recovery practices. NEW ORLEANS, LA, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- In a …

Scottsdale Practice Embraces Advanced Technology to Shape the Future of Cosmetic Dentistry

Transform your smile with Arizona's leading cosmetic dental experts. SCOTTSDALE, AZ, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- The integration of advanced technology in cosmetic dentistry is reshaping the patient experience and …

Butterfly Wellness Introduces Shammah: The World's First Psychodermatology Chatbot

This press release is about Butterfly Wellness' Launch of Shammah, the Uk's First Psychodermatology Chatbot for Holistic Skin and Mental Health Support. LONDON, LONDON, UNITED KINGDOM, December 21, 2024 /⁨EINPresswire.com⁩/ -- Butterfly …

Iowa Gov. Kim Reynolds Announces Higley Partners to Receive $2 Million For Addiction Center

Historic Cedar Rapids property to transform into Radix Recovery, a 68-bed addiction center, with $2 million state grant and local partnerships. CEDAR RAPIDS, CO, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- Throughout the decades the …

SurveySlack Launches New Survey Platform to Maximize User Engagement and Feedback

SurveySlack simplifies survey creation with customizable templates, AI-driven questions, real-time analytics, and branching logic to boost engagement. AHMEDABAD, GUJARAT, INDIA, December 21, 2024 /⁨EINPresswire.com⁩/ -- SurveySlack has launched a …

Smile4EverMexico Announces New Single-Visit Tooth Restoration Option

TIJUANA, MEXICO, December 21, 2024 /⁨EINPresswire.com⁩/ -- Smile4EverMexico, a clinic specializing in border dentistry, is pleased to announce it has introduced a new service in dental care: complete tooth restoration treatments that can be …

Dr. Yorell Manon Matos Launches Transformative Healthcare Education Grant to Cultivate Next Generation of Medical ...

SIOUX FALLS, S.D., Dec. 21, 2024 (GLOBE NEWSWIRE) -- Distinguished hand surgeon Dr. Yorell Manon-Matos announces the establishment of a groundbreaking academic grant program designed to nurture emerging talent in healthcare education. The Dr. Yorell Manon …

Dr. Kent Scheff Announces the Launch of the Dr. Kent Scheff Scholarship for Sports Medicine

ST. PAUL, Minn., Dec. 21, 2024 (GLOBE NEWSWIRE) -- Dr. Kent Scheff, a renowned physician specializing in Primary Care Sports Medicine, is pleased to announce the launch of the Dr. Kent Scheff Scholarship for Sports Medicine, an annual scholarship program …

NHS warns of ‘bargain basement’ BBLs in run up to Christmas

England’s top doctor is warning the public about the risk of ‘bargain-basement’ Brazilian Butt lifts, following a stream of deals being offered by overseas clinics in the run up to Christmas.  The NHS has seen clinics offering 25% discounts, all-inclusive …

NASP Tells Congress and the Incoming Trump Administration: Pharmacies and Patients Can’t Continue to Wait for PBM ...

Washington, DC, Dec. 21, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy issued the following statement: As the non-profit trade organization representing specialty pharmacies that support patients with significant and complex …

International Non-profits call for mandatory device-based age verification

The International Centre for Missing and Exploited Children is committed to advancing child protection and safeguarding vulnerable children around the world. ALEXANDRIA, VA, UNITED STATES, December 20, 2024 /⁨EINPresswire.com⁩/ -- While the …

Colorado adopts nation-leading standard to cut greenhouse gas emissions from oil and gas

Denver (Dec. 20, 2024): The Colorado Air Quality Control Commission adopted a groundbreaking new rule aimed at significantly further reducing greenhouse gas emissions from the state’s oil and gas industry. The rule addresses emissions from midstream oil …

Heavenly Spa By Westin™ at The Westin® Fort Lauderdale Beach Resort Completes an Elaborate Renovation

Spa Enthusiasts Can Enjoy a Wellness Journey Inspired by Serene Destinations Worldwide with New Treatments, an Infrared Sauna and Exclusive Retail Products FORT LAUDERDALE, FL, UNITED STATES, December 20, 2024 /⁨EINPresswire.com⁩/ -- Heavenly Spa …

Lucid Dreaming Devices Market Forecasted to Reach USD 196.8 Million by 2034, Growing at a CAGR of 5.1% | TMR

The lucid dreaming devices market is gaining traction as individuals seek tools to control and enhance their dream experiences for wellness or research. WILMINGTON, DE, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- The global lucid …

Medical Biomimetics Market Expected to Reach USD 19.3 Billion by 2034, With a CAGR of 6.8% |Transparency Market Research

The medical biomimetics market is advancing as biomimetic technologies offer solutions for tissue regeneration and healing in medical applications. WILMINGTON, DE, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- The global medical …

Lymphedema Diagnostics Market to Reach USD 70.7 Million by 2034, Growing at a CAGR of 4.8% |Transparency Market Research

The lymphedema diagnostics market is expanding with innovative solutions for early detection and management of this chronic condition. WILMINGTON, DE, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- The global lymphedema diagnostics …

Patient Monitoring and Ultrasound Devices Display Market Projected to Exceed USD 10.6 Billion by 2034 | TMR

The market for patient monitoring and ultrasound devices display is growing with advancements in real-time health monitoring and diagnostics WILMINGTON, DE, UNITED STATES, December 21, 2024 /⁨EINPresswire.com⁩/ -- The global patient monitoring and …

Catarina Malmrot's new book, Secrets of Sustainable Leadership, reaches #1 International Bestseller Status

Leadership Expert Catarina Malmrot Shares Her Holistic Approach to Quality Management and Leadership STOCKHOLM, SWEDEN, December 20, 2024 /⁨EINPresswire.com⁩/ -- Catarina Malmrot’s latest book, Secrets of Sustainable Leadership: A Holistic …

Glaucoma Treatment Market 2034: FDA Approval, Clinical Trials, Medication, Companies by DelveInsight

Glaucoma companies are Allergan, Santen Pharmaceutical, D.Western Therapeutics Institute, Kowa Ltd., Alcon, Senju Pharmaceuticals, Otsuka Pharmaceuticals, ETC ALBANY, NY, UNITED STATES, December 20, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight's …